I have a very strong opinion that none of their patents will hold up and that there will be ZERO royalties paid to them on bapineuzumab. At the most, Pfe/JNJ might pay them to go away, but not even sure about that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.